Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Accounts Payables (2020 - 2025)

Historic Accounts Payables for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $4.8 million.

  • Burning Rock Biotech's Accounts Payables rose 3401.06% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year increase of 3401.06%. This contributed to the annual value of $4.6 million for FY2024, which is 8172.17% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Accounts Payables of $4.8 million as of Q3 2025, which was up 3401.06% from $4.5 million recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Accounts Payables peaked at $27.1 million during Q4 2021, and registered a low of $2.5 million during Q4 2023.
  • Over the past 5 years, Burning Rock Biotech's median Accounts Payables value was $4.8 million (recorded in 2025), while the average stood at $7.0 million.
  • In the last 5 years, Burning Rock Biotech's Accounts Payables skyrocketed by 39838.18% in 2021 and then plummeted by 7775.55% in 2023.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Accounts Payables stood at $27.1 million in 2021, then plummeted by 72.74% to $7.4 million in 2022, then crashed by 65.56% to $2.5 million in 2023, then soared by 81.72% to $4.6 million in 2024, then increased by 4.15% to $4.8 million in 2025.
  • Its Accounts Payables stands at $4.8 million for Q3 2025, versus $4.5 million for Q2 2025 and $5.0 million for Q1 2025.